Navigation Links
Sanofi Announces Positive Phase 3 Results for Investigational New Insulin U300
Date:6/22/2013

insulin U300 during the study period compared to the Lantus® group (45.3% vs. 59.7%; RR 0.76; 95% CI 0.66 to 0.87). New insulin U300 was well-tolerated in this study, with no differences in other adverse events observed from Lantus®.

The EDITION I abstract is titled: New Insulin Glargine Formulation: Glucose Control and Hypoglycemia in People with Type 2 Diabetes Using Basal and Mealtime Insulin (EDITION I) (Riddle, MC et al) [Abstract no. 43-LB]EDITION II Topline results of EDITION II are consistent with EDITION I findings. EDITION II demonstrated that investigational new insulin U300 achieved similar blood sugar reduction while fewer patients experienced night-time low blood sugar events compared with Lantus®.

EDITION II evaluated efficacy and safety of new insulin U300 in a type 2 diabetes population (811 patients) treated with basal insulin plus oral antidiabetic therapy. The full EDITION II results will be submitted for presentation at upcoming scientific meetings.

"There remains a substantial unmet need in people with diabetes taking oral medication or insulin as many of them do not reach their glycemic goals," said Pierre Chancel, Senior Vice President, Global Diabetes, Sanofi. "With the investigational new insulin U300, we are striving to further enhance the clinical value of basal insulin, while building on the wealth of evidence of Lantus®, the world's most prescribed insulin."

About investigational new insulin U300Investigational new insulin U300 is a new formulation based on the glargine molecule, the biological entity of Lantus®, with its well established efficacy and safety profile. However, new insulin U300 has unique pharmacokinetic and pharmacodynamic profiles with studies demonstrating it has even flatter and more prolonged profiles than Lantus®.1,2 New insulin U300 also offers the benef
'/>"/>

SOURCE Sanofi
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes
2. Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
3. Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
4. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
5. Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
6. Tolero Pharmaceuticals announces Worldwide Agreement with Sanofi for the In-license of Alvocidib (Flavopiridol)
7. NextBio Announces Translational Medicine Partnership with Sanofi
8. Hemodialysis Patient Share for Sanofis Ferrlecit Increased Significantly in the First Quarter of 2013 Compared to the Previous Quarter
9. Sanofi US Offers a New Way to Say "Thank You" and Recognize the Unsung Heroes of Severe Allergy Awareness
10. Sanofi and Regeneron Report Positive Proof-of-Concept Data for Dupilumab, an IL-4R alpha Antibody, in Atopic Dermatitis
11. Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Oct. 22, 2014  Rescheduling of hydrocodone combination ... the pain market, according to a new primary ... firm providing market research and consultation exclusively in ... - http://photos.prnewswire.com/prnh/20141021/153440 In ... hydrocodone combination products from Schedule III to Schedule ...
(Date:10/22/2014)... 2014 Investor-Edge has initiated coverage ... FOLD ), Progenics Pharmaceuticals Inc. (NASDAQ: ... ), Idera Pharmaceuticals Inc. (NASDAQ: IDRA ), ... these five companies can be accessed at: http://investor-edge.com/register ... NASDAQ Composite ended at 4,419.48, up 2.40%, the Dow ...
(Date:10/22/2014)... Oct. 22, 2014  Charlene Vernak, RPh, of Vernak Farms ... recently was awarded the George Roentsch Scholarship by the ... award in Houston during PCCA,s ... awarded annually to an independent pharmacist and PCCA member ... George Roentsch , a well-known pharmacist in the compounding ...
Breaking Medicine Technology:Hydrocodone: Rescheduled, Repositioned & Reinvented 2Hydrocodone: Rescheduled, Repositioned & Reinvented 3Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 2Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 3Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 4Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 5PCCA Awards Charlene Vernak, RPh, the George Roentsch Scholarship 2
... 2011 A. John Blair III, MD, CEO of MedAllies, ... present at the July 15 eHealth Initiative 2011 National Forum ... Blair will participate in a panel session entitled "How HIEs ... implementation challenges associated with the Direct Project as well as ...
... 2011 B. Braun Medical Inc. (B. Braun) ... 7,933,780, which was issued April 26, 2011, and ... related to enhanced communication between medical devices and ... (Logo: http://photos.prnewswire.com/prnh/20081022/NYW008LOGO) "The addition ...
Cached Medicine Technology:A. John Blair III, MD, to Present at eHealth Initiative HIE Forum 2A. John Blair III, MD, to Present at eHealth Initiative HIE Forum 3B. Braun Acquires Patent for Enhanced Wireless Communication Between Medical Devices and Hospital Information Management Systems 2
(Date:10/22/2014)... Lexington, Kentucky (PRWEB) October 22, 2014 ... an agreement that will change the current location of ... Road to South Limestone across from the University of ... be a state-of-the-art ambulatory care center, owned and operated ... meet the orthopaedic needs of children and their families ...
(Date:10/22/2014)... Pass, OR (PRWEB) October 22, 2014 ... Southern California’s fresh water supply runs dangerously low, Southern ... change. Southern Oregon’s rivers, despite the lowest mountain snow ... even in late summer and early autumn.* That was ... authors of the new book “Hiking Southern Oregon,” during ...
(Date:10/22/2014)... 2014 Although there are only 24 hours in ... people who have trouble finding time within their busy schedules for ... long periods of time to get in shape. Here are five ... the go. , Change Up Your Commute , Consider riding ... add some exercise into your daily routine. If you must use ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 ... may be showing a genetic propensity for obesity as toddlers, ... been linked to increased body fat, but the same genes ... the researchers said. At 1 year, kids with these ... 3, however, these genes were linked to excessive weight gain, ...
(Date:10/22/2014)... Maureen Salamon HealthDay ... A crucial part of conventional in vitro fertilization (IVF) -- ... instead take place in a device inside the vagina, new ... contend that the device, called an INVOcell, might sharply cut ... also make the technology more accessible to those who don,t ...
Breaking Medicine News(10 mins):Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 2Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 2Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 4Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4
... May 14 Pre-hospital emergency care in the ... factors improving the quality of healthcare across Europe. ... to epidemiological reasons, accidents and terrorist activities, ambulance ... providers. To ensure efficiency and enhance ambulance services, ...
... May 14 Concentric Medical, Inc., the global leader ... of the 500th patient in its Merci Registry, a ... Merci Retrieval System(TM). The Registry has enrolled patients from ... patients. The Registry is the largest repository of data ...
... City-wide Rosters to Include Thousands of ... Specialty and Location SANTA FE, N.M., May 14 ... is launching a new quarterly health feature called "Most Influential ... database provides consumers with access to valuable healthcare information that,s ...
... today announced the addition of an outpatient appointment calendar ... software, fully matching the features of pMDsoft for BlackBerry. ... saves time that can be spent with patients, and ... on the go. Software interfaces allow pMDsoft to ...
... 14 The International Sports Sciences Association (ISSA) announced ... of Defense for the Military Spouse Career Advancement Account ... will officially open its doors for eligible military spouses, ... high growth, high demand fields. MyCAA provides up ...
... of patients have neuropathy onset during their 30s-60sNEW YORK, ... of peripheral neuropathy patients finds that the majority of ... adult years, with 82% experiencing neuropathy,s onset between the ... it affects all ages, all types of people," ...
Cached Medicine News:Health News:Focus on Rapid Medical Response to Improve the Quality of Healthcare and Drive the Ambulance Services Market in Europe, According to Frost & Sullivan 2Health News:Focus on Rapid Medical Response to Improve the Quality of Healthcare and Drive the Ambulance Services Market in Europe, According to Frost & Sullivan 3Health News:Focus on Rapid Medical Response to Improve the Quality of Healthcare and Drive the Ambulance Services Market in Europe, According to Frost & Sullivan 4Health News:Concentric Medical Announces Enrollment Milestone for Merci Registry 2Health News:Concentric Medical Announces Enrollment Milestone for Merci Registry 3Health News:Qforma Launches New Database to Help Consumers Find Top Community Medical Experts 2Health News:Qforma Launches New Database to Help Consumers Find Top Community Medical Experts 3Health News:pMDsoft Adds Mobile Appointment Calendar to iPhone Charge Capture Software 2Health News:pMDsoft Adds Mobile Appointment Calendar to iPhone Charge Capture Software 3Health News:pMDsoft Adds Mobile Appointment Calendar to iPhone Charge Capture Software 4Health News:Department of Defense Approves ISSA as Fitness Education Provider to Military Spouses 2Health News:First-Time National Poll Confirms Neuropathy Hits Millions in Their Prime 2Health News:First-Time National Poll Confirms Neuropathy Hits Millions in Their Prime 3Health News:First-Time National Poll Confirms Neuropathy Hits Millions in Their Prime 4
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
... offers a wide variety of financing options ... We are a direct lender to dentists ... finance has proven invaluable to our clients. ... and again for financial services because we ...
The Electri-Cool® II is the premier choice when it comes to localized cold therapy systems. system offers the widest variety of application-specific pads and wraps, for your convenience....
Medicine Products: